At present, programmed cell death 1/programmed cell death ligand 1 (PD1/PDL1) and cytotoxic T lymphocyte-associated protein 4 (CTLA4) are the most well-studied signals and have shown impressive therapeutic benefits in different cancers (8–10). Here, CTLA4 is linked to cancer.